Wilma Bergman

Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994.

J. Vandenbroucke, F. Rosendaal, N. Gruis, 1998, The Journal of investigative dermatology.

Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic.

N. Gruis, W. Bergman, E. Hille, 1999, Journal of the American Academy of Dermatology.

Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9.

L. Sandkuijl, N. Gruis, W. Bergman, 1994, The Journal of investigative dermatology.

Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.

L. Sandkuijl, N. Gruis, W. Bergman, 2001, American journal of human genetics.

Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives

W. Bergman, M. Jager, H. Kemme, 1998, Melanoma research.

Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.

N. Gruis, W. Bergman, R. Frants, 2001, Cancer research.

Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

S. Puig, E. Gillanders, D. Elder, 2010, Journal of the National Cancer Institute.